Cxbladder Is a Suite of Tests Designed To Rule Out Urothelial Bladder Cancer

Cxbladder is a suite of non-invasive genomic urine tests optimised for haematuria evaluation and the surveillance of non-muscle invasive bladder cancer.

Cxbladder is a suite of non-invasive genomic urine tests optimized for the rule out of urothelial bladder cancer, the most common form of the disease. The test combines clinical risk factors with gene expression markers to quickly and accurately rule out  cancer, reducing the need for further invasive procedures when you're at low risk of disease.

You should consider a Cxbladder test when you’ve seen blood in your urine, when tests reveal you have blood in your urine, or when you’ve had non-muscle invasive bladder cancer and are being monitored for recurrence. A Cxbladder test can provide peace of mind, helping to resolving diagnostic ambiguity while reducing the need for invasive cystoscopies which can be uncomfortable and inconvenient. As a non-invasive monitoring alternative, the test can reduce the frequency of surveillance cystoscopy required in many patients.

With performance validated in over 20 peer-reviewed studies, Cxbladder’s proven accuracy makes it a reliable choice.

Take control of your care. Cxbladder provides meaningful results that will help you and your doctor make informed diagnosis and management decisions.
Learn more about Cxbladder     Contact us for more information

Bladder Cancer Detection

Globally, bladder cancer is the sixth most common cancer in men, and the 10th most common overall. The most common sign of bladder cancer is blood in urine (or hematuria), however patients may experience a range of other symptoms such as urinary irritation and/ or changes in the frequency, urgency, or ease of urination.

Several tests and procedures are available to determine whether an individual has bladder cancer or to establish an alternative diagnosis. Some of these clarify the presence of symptoms (such as hematuria) and others identify alternative causes of these symptoms (such as an infection). Importantly, these tests and procedures are used in combination to determine an overall diagnosis.

Learn more about bladder cancer symptoms     Browse our overview of bladder cancer detection

Tests and procedures used in detection, rule-out, and diagnosis include:

Urine Test Detection

Urine-based Tests
Non-invasive urine-based tests can be used to determine if blood or other substances are present in a sample, whether an infection may be the root cause of symptoms, and if microscopic cancer or pre-cancer cells are visible. Genomic tests like Cxbladder analyse biomarker genes to help rule out cancer, reducing the need for further invasive procedures.
Learn more about urine test detection


Cystoscopy involves inserting a thin tube with a light and camera through the urethra to look inside the bladder. This procedure is usually recommended if cancer is suspected.
Learn more about cystoscopy


Imaging techniques like an ultrasound, which use high frequency waves to produce images of internal organs and tissue, and CT scans, which use x-rays to obtain cross-sectional images of the body, are often used to determine if abnormalities are present, particularly in the upper urinary tract and kidneys.
Learn more about imaging techniques

Last Updated: 25 Jun 2021 11:29 am